Trade Summary

4 days ago, Dorval Allison, serving as Dir at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 11,610 shares at $7.20 per share, for a total transaction value of $83,579.23. Following this transaction, Dorval Allison now holds 90,780 shares of PBYI.

This sale represents a 11.34% decrease in Dorval Allison's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 (accepted Jun 15, 8:09 PM ET), 4 days after the trade was made.